» Articles » PMID: 21476911

Autophagy in Nonalcoholic Steatohepatitis

Overview
Specialty Gastroenterology
Date 2011 Apr 12
PMID 21476911
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a critical pathway for the degradation of intracellular components by lysosomes. Established functions for both macroautophagy and chaperone-mediated autophagy in hepatic lipid metabolism, insulin sensitivity and cellular injury suggest a number of potential mechanistic roles for autophagy in nonalcoholic steatohepatitis (NASH). Decreased autophagic function in particular may promote the initial development of hepatic steatosis and progression of steatosis to liver injury. Additional functions of autophagy in immune responses and carcinogenesis may also contribute to the development of NASH and its complications. The impairment in autophagy that occurs with cellular lipid accumulation, obesity and aging may therefore have an important impact on this disease, and agents to augment hepatic autophagy have therapeutic potential in NASH.

Citing Articles

Melanocortin 3 receptor regulates hepatic autophagy and systemic adiposity.

Patel T, Jun J, Seo A, Levi N, Elizondo D, Chen J Nat Commun. 2025; 16(1):1690.

PMID: 39956805 PMC: 11830824. DOI: 10.1038/s41467-025-56936-1.


Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells.

Moliterni C, Vari F, Schifano E, Tacconi S, Stanca E, Friuli M J Lipid Res. 2024; 65(12):100692.

PMID: 39505261 PMC: 11648247. DOI: 10.1016/j.jlr.2024.100692.


Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target.

Milani I, Codini M, Guarisco G, Chinucci M, Gaita C, Leonetti F Int J Mol Sci. 2024; 25(19).

PMID: 39409124 PMC: 11477334. DOI: 10.3390/ijms251910795.


Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.

Engin A Adv Exp Med Biol. 2024; 1460:539-574.

PMID: 39287864 DOI: 10.1007/978-3-031-63657-8_18.


Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.

Raza S, Rajak S, Yen P, Sinha R NPJ Metab Health Dis. 2024; 2(1):19.

PMID: 39100919 PMC: 11296953. DOI: 10.1038/s44324-024-00022-5.


References
1.
Saitoh T, Fujita N, Jang M, Uematsu S, Yang B, Satoh T . Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008; 456(7219):264-8. DOI: 10.1038/nature07383. View

2.
Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

3.
Cuervo A, Bergamini E, Brunk U, Droge W, Ffrench M, Terman A . Autophagy and aging: the importance of maintaining "clean" cells. Autophagy. 2006; 1(3):131-40. DOI: 10.4161/auto.1.3.2017. View

4.
Singh R, Wang Y, Xiang Y, Tanaka K, Gaarde W, Czaja M . Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology. 2008; 49(1):87-96. PMC: 2614457. DOI: 10.1002/hep.22578. View

5.
Day C, James O . Steatohepatitis: a tale of two "hits"?. Gastroenterology. 1998; 114(4):842-5. DOI: 10.1016/s0016-5085(98)70599-2. View